The neonatal blood spot metabolome in retinoblastoma
Background: Retinoblastoma is rare but nevertheless the most common pediatric eye cancer that occurs in children under age 5. High-resolution metabolomics (HRM) is a powerful analytical approach to profile metabolic features and pathways or identify metabolite biomarkers. To date, no studies have us...
Main Authors: | Qi Yan, Di He, Douglas I. Walker, Karan Uppal, Xuexia Wang, Helen T. Orimoloye, Dean P. Jones, Beate R. Ritz, Julia E. Heck |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | EJC Paediatric Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X23001216 |
Similar Items
-
Retinoblastoma
by: Francois Doz, et al.
Published: (2019-09-01) -
Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels
by: Vishnu Suresh Babu, et al.
Published: (2022-10-01) -
Neonatal retinoblastoma
by: Tero T Kivelä, et al.
Published: (2017-01-01) -
Managing and treating intraocular retinoblastoma
by: Ashwin Reddy, et al.
Published: (2018-05-01) -
Lesions simulating retinoblastoma at a tertiary care center
by: Fariba Ghassemi, et al.
Published: (2015-01-01)